CHEK2 and breast carcinoma: However, to high breast cancer risk associated with alterations in BRCA1 or BRCA2, both studies confirmed association of germline pathogenic CHEK2 variants with moderate breast cancer risk with odds ratio (OR) 2.5 and a cumulative lifetime breast cancer risk of 25%–30%.